Active substance
Results for the substance nilotinib
16 results
About this active substance
Nilotinib is a medication used for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML). It belongs to the class of tyrosine kinase inhibitors and works by blocking the activity of abnormal proteins that drive cancer cell growth.
The medication is taken orally, usually twice daily on an empty stomach. The dose is adjusted based on the patient's condition and response to treatment. Common side effects include nausea, fatigue, headaches, and skin rashes.
Nilotinib is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. It should also be used with caution in patients with cardiac or hepatic conditions.
This medication is an important option for patients with CML, helping to control the disease and improve their quality of life.
The medication is taken orally, usually twice daily on an empty stomach. The dose is adjusted based on the patient's condition and response to treatment. Common side effects include nausea, fatigue, headaches, and skin rashes.
Nilotinib is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. It should also be used with caution in patients with cardiac or hepatic conditions.
This medication is an important option for patients with CML, helping to control the disease and improve their quality of life.
-
-
KRUFTON 200mg capsules EGIS
-
NILOTINIB ACCORD 150mg capsules
-
KRUFTON 150mg capsules EGIS
-
NILOTINIB STADA 200mg capsules
-
NILOTINIB STADA 150mg capsules
-
NILOTINIB STADA 150mg capsules
-
TASIGNA 50mg capsules EUROPHARM ORIGINAL MEDICINE
-
TASIGNA 200mg capsules EUROPHARM ORIGINAL MEDICINE
-
TASIGNA 150mg capsules EUROPHARM ORIGINAL MEDICINE
-
NILOTINIB ZENTIVA 200mg capsules
-
NILOTINIB ZENTIVA 150mg capsules
-
NILOTINIB TEVA 150mg capsules
-
NILOTINIB TEVA 200mg capsules
-
NILOTINIB STADA 50mg capsules
-
KRUFTON 50mg capsules EGIS